Central banks in several major economies have kept interest rates steady while inflation in many places still comes from services and everyday costs. That mix keeps income focused investors searching for yield that looks more reliable than cash or short term bonds. Well covered, growing and stable dividends above 5% can stand out. This article walks through three Dividend Powerhouses from the screener that fit that brief.
The three stocks highlighted below are just a small sample, as the full Dividend Powerhouses screen surfaced 445 more companies with similarly compelling income stories that are not covered here. If you want to go straight to the source and identify, compare, and analyze your own high conviction ideas, head into the Dividend Powerhouses (3%+ Yield) screener.
Canon (TSE:7751)
Overview: Canon is a Japanese technology company that sells printers, cameras, medical imaging systems and industrial equipment worldwide, supplying everything from office and professional print gear to hospital scanners and semiconductor manufacturing tools.
Operations: Canon generates most of its revenue from Printing at about ¥2.5t, with additional contributions from Imaging at ¥1.1t, Medical at about ¥579b and Industrial at about ¥347b, plus smaller amounts from other activities and internal eliminations.
Market Cap: ¥3.9t
Canon stands out in a dividend screen because it combines a long established brand and broad product mix with signs of improving profitability and earnings momentum. Earnings grew well above the company’s 5 year trend and the wider Japanese tech sector, while net profit margins nearly doubled to 7.4%. Recent results show higher revenue and earnings per share, supported by high quality earnings and a large share buyback that has already retired more than 4% of shares. At the same time, the stock trades at a P/E that sits well below peers and some intrinsic value estimates. Investors need to weigh concerns around an unstable dividend record, modest growth forecasts and a funding structure reliant on external borrowing.
Canon’s mix of improving margins, high quality earnings and a low P/E hints at a story that many income investors may be underestimating. Get the fuller picture, including how the dividend trade off really looks today, in the 4 key rewards and 1 important warning sign
Build your own dividend and valuation shortlist around Canon
Canon and the other two stocks in this article came from the same Simply Wall St screener, yet the real value for you is in setting your own rules. Use our flexible Screener to mix filters like dividends, valuation, quality and risks, or start with any of our curated Investing Ideas.
Tokio Marine Holdings (TSE:8766)
Overview: Tokio Marine Holdings is a global insurance group that offers a wide range of non life and life insurance, reinsurance, asset management and other financial services across Japan, the United States and many international markets.
Operations: Tokio Marine Holdings generates most of its revenue from Overseas Insurance Business at about ¥5.2t, followed by Domestic Property and Casualty Insurance at about ¥3.1t, Domestic Life Insurance at about ¥354b and Solution and Other Business at about ¥328b, with smaller unallocated adjustments.
Market Cap: ¥14.7t
Income focused investors may find Tokio Marine Holdings worth a closer look because it mixes a long operating history and global reach with a 3.09% dividend, an active share buyback program and plans to reshape the business for higher earnings per share. Management is pushing the Re New program in Japan, expanding solution offerings like disaster resilience insurance and recycling capital from equity holdings into new deals. These initiatives are aimed at stronger profit growth and higher return on equity over time. The trade off is that current profit margins are compressed, the funding model leans heavily on external borrowing and recent earnings have been volatile. This makes Tokio Marine a case where the income, growth and risk factors all need to be weighed together.
Tokio Marine’s push to recycle capital and lift earnings per share has many investors focused on the headline 3.09% yield while missing how the full income and risk profile lines up in the 3 key rewards and 1 important warning sign
Daiichi Sankyo Company (TSE:4568)
Overview: Daiichi Sankyo Company is a global pharmaceutical company focused on cancer and cardiovascular treatments, with key drugs such as Enhertu, Datroway, Vanflyta and a range of therapies for conditions including iron deficiency, diabetes, migraine and osteoporosis.
Operations: Daiichi Sankyo Company generates all of its ¥2.2t revenue from its Pharmaceutical Operation segment.
Market Cap: ¥5.0t
Daiichi Sankyo Company is attracting attention because its oncology drugs, particularly Enhertu and Datroway, are gaining fresh approvals across the U.S., EU, China and other markets in 2026. This is expanding the pool of patients and supporting revenue growth. At the same time, analysts see upside in the stock relative to both their price targets and Simply Wall St’s cash flow valuation, although the P/E sits above the broader JP Pharmaceuticals industry. You need to balance that potential with real pressure points, including heavy reliance on a handful of blockbuster cancer drugs, rising R&D spend, board turnover and a dividend that is not well covered by free cash flow.
Accelerating oncology approvals and a rich P/E put Daiichi Sankyo Company at the center of a growth versus valuation puzzle that many investors only half see. Get the missing context inside the analyst forecasts for Daiichi Sankyo Company
Seeking Fresh Alternatives Before Others?
New ideas can move from quiet to crowded quickly. Spot fresh momentum and under the radar stories before the crowd, while the numbers still matter most, and consider acting while conditions remain favorable.
- Target resilient compounding potential by checking companies in the 56 resilient stocks with low risk scores that currently pair lower risk scores with balanced fundamentals.
- Explore infrastructure and compute trends by scanning the 55 AI infrastructure stocks packed with stocks positioned around AI data centers and supporting hardware demand.
- Look for potential asymmetric upside by reviewing the curated 63 high quality undiscovered gems where strong fundamentals are still flying under most investors’ radars.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com